AVATAR:

Making Vascular Access Complications History

Vascular access device insertion can be difficult and painful. And after insertion, 25% to 50% fail due to infection, blockage, dislodgement or vessel damage. Our goal is to make vascular access complications history.

AVATAR undertakes committed scientific work to improve health services and patient outcomes, to rigorously and independently test products and practices, and to promote local and global networks.

We strive to eliminate ineffective practices and replace them with innovative solutions, providing patients with a better healthcare experience and saving global healthcare providers hundreds of millions of dollars.

Alliance for Vascular Access Teaching and Research

Current Research Projects | AVATAR Group
Get Involved | AVATAR Groupp
Our Teaching | AVATAR Group
About AVATAR Group

Events Coming Up

For more, please click on our Events page

10th International Congress of Asia Pacific Society of Infection Control (APSIC)

20-23 January 2022
Singapore
https://apsic2022.com 

Latest News

17 December 2021
Central venous access devices
  What type of central venous access device does my patient have? Seen in a variety of clinical settings from ...
View All Latest News

Social Feed

RT @TriciaVAMS: Watch this space. Over the next couple of years we hope to improve PIVC outcomes for paediatrics https://t.co/2PIUpbj1Ie
51 days ago
@GriffithNursing@Griffith_Uni@Griffith_Health Wishing wonderful careers ahead for all of you!
52 days ago
Follow on twitter

Keep in Touch

Sign up to receive news about AVATAR.

Address

Griffith University
Nathan
Queensland
Australia 4111